{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:14:51Z","timestamp":1753877691596,"version":"3.41.2"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/omcr\/omz046","type":"journal-article","created":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T09:02:55Z","timestamp":1560502975000},"source":"Crossref","is-referenced-by-count":3,"title":["A case report of successful treatment of high-output heart failure secondary to hereditary haemorrhagic telangiectasia with bevacizumab"],"prefix":"10.1093","volume":"2019","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0983-2095","authenticated-orcid":false,"given":"Mark","family":"Flower","sequence":"first","affiliation":[{"name":"Redcliffe hospital, Anzac Ave, Qld Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Chern","sequence":"additional","affiliation":[{"name":"The University of Queensland, Herston, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,6,14]]},"reference":[{"key":"2019061408595291400_ref1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2796.1999.00398.x","article-title":"Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients","volume":"245","author":"Kjeldsen","year":"1999","journal-title":"J Intern Med"},{"key":"2019061408595291400_ref2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/humu.10026","article-title":"Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan","volume":"19","author":"Dakeishi","year":"2002","journal-title":"Hum Mutat"},{"key":"2019061408595291400_ref3","first-page":"3","article-title":"Epidemiological investigation of Rendu\u2013Osler disease in France: its geographical distribution and prevalence","volume":"44","author":"Bideau","year":"1989","journal-title":"Popul"},{"key":"2019061408595291400_ref4","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4240\/wjgs.v8.i12.792","article-title":"Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia","volume":"8","author":"Ou","year":"2016","journal-title":"World J Gastrointest Surg"},{"key":"2019061408595291400_ref5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3121\/cmr.2013.1205","article-title":"Blessing for the bleeder: bevacizumab in hereditary hemorrhagic telangiectasia","volume":"13","author":"Epperla","year":"2015","journal-title":"Clin Med Res"},{"key":"2019061408595291400_ref6","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMc0901421","article-title":"Bevacizumab in hereditary hemorrhagic telangiectasia","volume":"360","author":"Bose","year":"2009","journal-title":"N Engl J Med"},{"key":"2019061408595291400_ref7","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2012.250","article-title":"Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output","volume":"307","author":"Dupuis-Girod","year":"2012","journal-title":"JAMA"},{"key":"2019061408595291400_ref8","first-page":"210","article-title":"Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia","author":"Mitchell","year":"2008"},{"key":"2019061408595291400_ref9","doi-asserted-by":"crossref","first-page":"e1966","DOI":"10.1097\/MD.0000000000001966","article-title":"Bevacizumab to treat Cholangiopathy in hereditary hemorrhagic telangiectasia: be cautious: a case report","volume":"94","author":"Maestraggi","year":"2015","journal-title":"Medicine"},{"key":"2019061408595291400_ref10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/21645515.2015.1011960","article-title":"Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia","volume":"11","author":"Kochanowski","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"2019061408595291400_ref11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000323152","article-title":"A case report of a patient with hereditary hemorrhagic telangiectasia treated successively with thalidomide and bevacizumab","volume":"3","author":"Amanzada","year":"2010","journal-title":"Case Rep Oncol"}],"container-title":["Oxford Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/omcr\/article-pdf\/2019\/6\/omz046\/28825107\/omz046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T09:03:00Z","timestamp":1560502980000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/omcr\/article\/doi\/10.1093\/omcr\/omz046\/5519096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":11,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,14]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/omcr\/omz046","relation":{},"ISSN":["2053-8855"],"issn-type":[{"type":"electronic","value":"2053-8855"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,6,1]]},"article-number":"omz046"}}